Risk factor analysis of hypersensitivity reactions to abacavir
- 1 April 2002
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 24 (4) , 565-573
- https://doi.org/10.1016/s0149-2918(02)85132-3
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patientsAIDS, 2002
- Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavirPublished by Elsevier ,2001
- Idiosyncratic drug reactions: the reactive metabolite syndromesThe Lancet, 2000
- 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activityAntimicrobial Agents and Chemotherapy, 1997
- Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89Antimicrobial Agents and Chemotherapy, 1997
- Adverse Events from Drug Therapy for Human Immunodeficiency Virus DiseaseThe American Journal of Medicine, 1996